Yang, I., Nell, S., & Suerbaum, S. (2013). Survival in hostile territory: the microbiota of the stomach. FEMS Microbiology Reviews, 37(5), 736–61. doi:10.1111/1574–6976.12027

Yang, I., Woltemate, S., Piazuelo, M. B., Bravo, L. E., Yepez, M. C., Romero-Gallo, J., . Suerbaum, S. (2016). Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia. Scientific Reports, 6(18594). doi:10.1038/srep18594

7. Микробная Мекка: микробиом кишечника

Bala, S., Marcos, M., Gattu, A., Catalano, D., & Szabo, G. (2014). Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PloS One, 9(5), e96864. doi:10.1371/journal.pone.0096864

Baothman, O. A., Zamzami, M. A., Taher, I., Abubaker, J., & Abu-Farha, M. (2016). The role of Gut Microbiota in the development of obesity and Diabetes. Lipids in Health and Disease, 15(108). doi:10.1186/s12944-016–0278-4

Biagi, E., Franceschi, C., Rampelli, S., Severgnini, M., Ostan, R., Turroni, S., . Candela, M. (2016). Gut Microbiota and Extreme Longevity. Current Biology: CB, 26(11), 1480–85. doi:10.1016/j.cub.2016.04.016

Bian, G., Gloor, G. B., Gong, A., Jia, C., Zhang, W., Hu, J., . Li, J. (2017). The GutMicrobiota of Healthy Aged Chinese Is Similar to That of the Healthy Young. mSphere, 2(5). doi:10.1128/mSphere.00327-17

Brandt, L. J. (2017). Fecal Microbiota Therapy With a Focus on Clostridiumdifficile Infection. Psychosomatic Medicine, 79(8), 868–73. doi:10.1097/ PSY.0000000000000511

Brüssow, H. (2013). Microbiota and healthy ageing: observational and nutritional intervention studies. Microbial Biotechnology, 6(4), 326–34. doi:10.1111/1751–7915.12048

Chu, H., Khosravi, A., Kusumawardhani, I. P., Kwon, A. H., Vasconcelos, A. C., Cunha, L. D., . Mazmanian, S. K. (2016). Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science, 352(6289), 1116–20. doi:10.1126/science.aad9948

Deehan, E. C., & Walter, J. (2016). The Fiber Gap and the Disappearing Gut Microbiome: Implications for Human Nutrition. Trends in Endocrinology and Metabolism: TEM, 27(5), 239–42. doi:10.1016/j.tem.2016.03.001

Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., . Pedersen, O. (2015). Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature, 528(7581), 262–66. doi:10.1038/nature15766

Iyer, N., & Vaishnava, S. (2016). Alcohol Lowers Your (Intestinal) Inhibitions. Cell Host & Microbe, 19(2), 131–33. doi:10.1016/j.chom.2016.01.014

Jayasinghe, T. N., Chiavaroli, V., Holland, D. J., Cutfield, W. S., & O’Sullivan, J. M. (2016). The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation. Frontiers in cellular and Infection Microbiology, 6(15). doi:10.3389/fcimb.2016.00015

Kong, F., Hua, Y., Zeng, B., Ning, R., Li, Y., & Zhao, J. (2016). Gut microbiota signatures of longevity. Current Biology: CB, 26(18), R832–R833. doi:10.1016/j. cub.2016.08.015

Konig, J., Siebenhaar, A., Hogenauer, C., Arkkila, P., Nieuwdorp, M., Noren, T., . Brummer, R. J. (2017). Consensus report: faecal microbiota transfer – clinical applications and procedures. Alimentary Pharmacology & Therapeutics, 45(2), 222–39. doi:10.1111/apt.13868

Leung, C., Rivera, L., Furness, J. B., & Angus, P. W. (2016). The role of the gut microbiota in NAFLD. Nature reviews. Gastroenterology & НАООСtology, 13(7), 412–25. doi:10.1038/nrgastro.2016.85

Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014). Clinical consequences of polypharmacy in elderly. Expert Opinion on Drug Safety, 13(1), 57–65. doi:10.15 17/14740338.2013.827660

Santoro, A., Ostan, R., Candela, M., Biagi, E., Brigidi, P., Capri, M., & Franceschi, C. (2018). Gut microbiota changes in the extreme decades of human life: a focus on centenarians. Cellular and Molecular Life Sciences: CMLS, 75(1), 129–48. doi:10.1007/s00018-017–2674-y

Sonnenburg, E. D., Smits, S. A., Tikhonov, M., Higginbottom, S. K., Wingreen, N. S., & Sonnenburg, J. L. (2016). Diet-induced extinctions in the gut microbiota compound over generations. Nature, 529(7585), 212–15. doi:10.1038/nature16504

Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C. A., Maza, O., . Elinav, E. (2014). Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature, 514(7521), 181–86. doi:10.1038/nature13793

Thaiss, C. A., Itav, S., Rothschild, D., Meijer, M., Levy, M., Moresi, C., . Elinav, E. (2016). Persistent microbiome alterations modulate the rate of post-dieting weight regain. Nature, 540, 544–51. doi:10.1038/nature20796

Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., . Segal, E. (2015). Personalized Nutrition by Prediction of Glycemic Responses. Cell, 163(5), 1079–94. doi:10.1016/j.cell.2015.11.001

8. Микробная любовь: сердце и микробиом

American Heart Association. (2017). Good Fats and Bad Fats: The Facts on Healthy Fats. Retrieved from healthyforgood.heart.org/eat-smart/infographics/the-factson-fats

Bala, S., Marcos, M., Gattu, A., Catalano, D., & Szabo, G. (2014). Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PloS One, 9(5), e96864. doi:10.1371/journal.pone.0096864

Chen, M. L., Yi, L., Zhang, Y., Zhou, X., Ran, L., Yang, J., . Mi, M. T. (2016). Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. mBio, 7(2), e02210-02215. doi:10.1128/mBio.02210-15

Clarke, S. F., Murphy, E. F., O’Sullivan, O., Lucey, A. J., Humphreys, M., Hogan, A., . Cotter, P. D. (2014). Exercise and associated dietary extremes impact on gut microbial diversity. Gut, 63(12), 1913–20. doi:10.1136/gutjnl-2013–306541

Gregory, J. C., Buffa, J. A., Org, E., Wang, Z., Levison, B. S., Zhu, W., . Hazen, S. L. (2015). Transmission of atherosclerosis susceptibility with gut microbial transplantation. The Journal of Biological Chemistry, 290(9), 5647–60. doi:10.1074/jbc.M114.618249

Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., . Hazen, S. L. (2013). Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature Medicine, 19(5), 576–85. doi:10.1038/nm.3145

Teicholz, N. (2014). The Big Fat Surprise: Why Butter, Meat and Cheese Belong in a Healthy Diet. New York, NY: Simon & Schuster Paperbacks.

Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., . Hazen, S. L. (2015). Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell, 163(7), 1585–95. doi:10.1016/j. cell.2015.11.055